Cargando…

Anti-apoptotic ARC protein confers chemoresistance by controlling leukemia-microenvironment interactions through a NFκB/IL1β signaling network

To better understand how the apoptosis repressor with caspase recruitment domain (ARC) protein confers drug resistance in acute myeloid leukemia (AML), we investigated the role of ARC in regulating leukemia-mesenchymal stromal cell (MSC) interactions. In addition to the previously reported effect on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carter, Bing Z., Mak, Po Yee, Chen, Ye, Mak, Duncan H., Mu, Hong, Jacamo, Rodrigo, Ruvolo, Vivian, Arold, Stefan T., Ladbury, John E., Burks, Jared K., Kornblau, Steven, Andreeff, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991438/ https://www.ncbi.nlm.nih.gov/pubmed/26956049 http://dx.doi.org/10.18632/oncotarget.7911

Ejemplares similares

Targeting MCL-1 dysregulates cell metabolism and leukemia-stroma interactions and re-sensitizes acute myeloid leukemia to BCL-2 inhibition
por: Carter, Bing Z., et al.
Publicado: (2020)

Tumor Trp53 status and genotype affect the bone marrow microenvironment in acute myeloid leukemia
por: Jacamo, Rodrigo, et al.
Publicado: (2017)

MDM2 Inhibitor, Nutlin 3a, Induces p53 Dependent Autophagy in Acute Leukemia by AMP Kinase Activation
por: Borthakur, Gautam, et al.
Publicado: (2015)

Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34(+) proliferating and quiescent chronic myeloid leukemia blast crisis cells
por: Carter, Bing Z., et al.
Publicado: (2015)

Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics
por: Carter, Bing Z., et al.
Publicado: (2023)

Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics
por: Carter, Bing Z., et al.
Publicado: (2023)

Combined inhibition of MDM2 and BCR-ABL1 tyrosine kinase targets chronic myeloid leukemia stem/progenitor cells in a murine model
por: Carter, Bing Z., et al.
Publicado: (2020)

Inhibition of menin, BCL-2, and FLT3 combined with a hypomethylating agent cures NPM1/FLT3-ITD/-TKD mutant acute myeloid leukemia in a patient-derived xenograft model
por: Carter, Bing Z., et al.
Publicado: (2023)

Extended live-cell barcoding approach for multiplexed mass cytometry
por: Muftuoglu, Muharrem, et al.
Publicado: (2021)

Low Expression Of PP2A Regulatory Subunit B55α Is Associated With T308 Phosphorylation Of AKT And Shorter Complete Remission Duration In Acute Myeloid Leukemia Patients
por: Ruvolo, Peter P., et al.
Publicado: (2011)

Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survival
por: Kornblau, Steven M., et al.
Publicado: (2018)

Volumetric modulated arc therapy (VMAT) for hippocampal-avoidance whole brain radiation therapy: planning comparison with Dual-arc and Split-arc partial-field techniques
por: Yuen, Adams Hei Long, et al.
Publicado: (2020)

Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models
por: Han, Lina, et al.
Publicado: (2020)

EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player?
por: Di Vito Nolfi, Mauro, et al.
Publicado: (2022)

Origins of the Tumor Microenvironment: Quantitative Assessment of Adipose-Derived and Bone Marrow–Derived Stroma
por: Kidd, Shannon, et al.
Publicado: (2012)

Phosphorylation of GSK3α/β correlates with activation of AKT and is prognostic for poor overall survival in acute myeloid leukemia patients
por: Ruvolo, Peter P., et al.
Publicado: (2015)

LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AML
por: Ruvolo, Peter P., et al.
Publicado: (2019)

AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill F LT 3-ITD acute myeloid leukemia
por: Post, Sean M., et al.
Publicado: (2021)

Combined inhibition of β-catenin and Bcr–Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo
por: Zhou, H, et al.
Publicado: (2017)

Rapid monoisotopic cisplatin based barcoding for multiplexed mass cytometry
por: McCarthy, Ryan L., et al.
Publicado: (2017)

Hybrid split-arc partial-field volumetric modulated arc therapy: an improved beam arrangement for linear accelerator-based hippocampal-avoidance whole brain radiation therapy
por: Yuen, Adams Hei Long, et al.
Publicado: (2022)

Chemoresistance in human ovarian cancer: the role of apoptotic regulators
por: Fraser, Michael, et al.
Publicado: (2003)

Chemoresistance and the Self-Maintaining Tumor Microenvironment
por: Yeldag, Gulcen, et al.
Publicado: (2018)

Combinatorial targeting of XPO1 and FLT3 exerts synergistic anti-leukemia effects through induction of differentiation and apoptosis in FLT3-mutated acute myeloid leukemias: from concept to clinical trial
por: Zhang, Weiguo, et al.
Publicado: (2018)

Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD/D835 mutant AML
por: Yamatani, Kotoko, et al.
Publicado: (2022)

Enhanced TP53 reactivation disrupts MYC transcriptional program and overcomes venetoclax resistance in acute myeloid leukemias
por: Nishida, Yuki, et al.
Publicado: (2023)

Volumetric modulated arc therapy based total marrow and lymphoid irradiation: Workflow and clinical experience
por: Ladbury, Colton, et al.
Publicado: (2023)

Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastoma
por: Hastings, Jordan F., et al.
Publicado: (2023)

Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells
por: Abrams, Stephen L., et al.
Publicado: (2017)

Fibroblast-mediated uncaging of cancer cells and dynamic evolution of the physical microenvironment
por: Liu, Chang, et al.
Publicado: (2022)

Anexelekto/MER tyrosine kinase inhibitor ONO-7475 arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanisms
por: Ruvolo, Peter P., et al.
Publicado: (2017)

Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier
por: Da Ros, Martina, et al.
Publicado: (2018)

p53 Signaling on Microenvironment and Its Contribution to Tissue Chemoresistance
por: Souza, Leonel Cardozo de Menezes e, et al.
Publicado: (2022)

MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem/ progenitor cells
por: Zeng, Zhihong, et al.
Publicado: (2016)

Esophageal adenocarcinoma microenvironment: Peritumoral adipose tissue effects associated with chemoresistance
por: Carraro, Amedeo, et al.
Publicado: (2017)

The Role of Tumor Microenvironment in Chemoresistance: 3D Extracellular Matrices as Accomplices
por: Senthebane, Dimakatso Alice, et al.
Publicado: (2018)

The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
por: Senthebane, Dimakatso Alice, et al.
Publicado: (2017)

Manipulating the Tumor Microenvironment in Tumor Organoids Induces Phenotypic Changes and Chemoresistance
por: Dominijanni, Anthony, et al.
Publicado: (2020)

The bone marrow microenvironment as a mediator of chemoresistance in acute lymphoblastic leukemia
por: Meyer, Lauren K., et al.
Publicado: (2019)

Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality
por: Yu, Lei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8dtcdb0dcohal14iskuprahtem